Role of Janus Kinase inhibitors in the management of pulmonary involvement due to Long COVID-19 disease: A case control study

Role of Janus Kinase inhibitors in the management of pulmonary involvement due to Long COVID-19 disease: A case control study

OBJECTIVES: Ongoing symptomatic coronavirus disease 2019 (OSC) is defined as persistent symptoms beyond 4 weeks of acute illness. OSC leads to prolonged hospitalization and oxygen dependence. We aimed to find the outcome of Janus kinase inhibitors (JAKi) as a steroid-sparing agent to treat OSC. METH...

Full description

Saved in:
Bibliographic Details
Main Authors: Pawan Kumar Singh, Vinod Kumar Sharma, Lokesh Kumar Lalwani, Dhruva Chaudhry, Manjunath B. Govindagoudar, Chaudhari Pramod Sriram, Aman Ahuja
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-07-01
Series:Turkish Journal of Emergency Medicine
Subjects:
baricitinib
janus kinase inhibitors
long coronavirus disease 2019
postcoronavirus disease
tofacitinib
Online Access:https://journals.lww.com/10.4103/tjem.tjem_363_22
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.4103/tjem.tjem_363_22

Similar Items